Skip to main content
Wednesday
August 17, 2022
Sign In
Subscribe
Home
Economy
Stocks
Analysis
World+Biz
Sports
Features
Epaper
More
Subscribe
COVID-19
Bangladesh
Splash
Videos
Games
Long Read
Infograph
Interviews
Offbeat
Thoughts
Podcast
Quiz
Tech
Archive
Trial By Trivia
Magazine
Supplement
বাংলা
WEDNESDAY,
AUGUST 17, 2022
Bharat Biotech Covid-19 vaccine
Coronavirus chronicle
India gives nod to Bharat Biotech for intranasal Covid booster doses
The trials will be held at nice different sites
Coronavirus chronicle
WHO issues emergency use listing for COVAXIN Covid-19 jab
Coronavirus chronicle
India recommends homemade Covid-19 vaccine for kids aged 2 and above
Coronavirus chronicle
India to miss end-July vaccination target as Bharat Biotech lags
Coronavirus chronicle
India's Bharat Biotech says regulatory steps taken for Brazil vaccine contract
Coronavirus chronicle
Brazil official warned Bolsonaro over pressure to buy Bharat vaccine
Coronavirus chronicle
Covaxin 77.8% effective in phase 3 trial data
Coronavirus chronicle
FDA rejects emergency use authorization of Bharat Biotech’s Covaxin jab
Coronavirus chronicle
Covaxin’s US approval delayed over data, Bharat Biotech’s partner to file for full approval
Coronavirus chronicle
Bharat Biotech submits ‘90% of documents’ for WHO nod
Coronavirus chronicle
Bharat Biotech reduces Covaxin's price from Rs600 to Rs400 per dose for Indian states
Coronavirus chronicle
Narendra Modi gets second dose of Covid vaccine
Coronavirus chronicle
India's drug regulator panel eases use condition for home-grown vaccine
Show More